Company Overview
Snapshot
Founded in May 2024 by Gil Horsky, Shay Hilel, and Prof. Maayan, Lembas operates with 1–10 employees. The company has secured funding across one round from four investors, with FLORA Ventures identified as a lead investor. In June 2025, Lembas emerged from stealth, announcing its breakthrough discovery in natural GLP-1 for weight management.
Business overview
Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, leveraging an AI-powered discovery platform. Its core product, GLP-1 Edge™, is a food-grade peptide designed to enhance the body’s GLP-1 response, supporting appetite regulation and metabolic health. This technology allows for natural weight management without pharmaceutical intervention, targeting the functional food and supplement markets within the Agriculture & Food Technologies sector.
Strategic signal
In June 2025, Lembas emerged from stealth mode, unveiling its GLP-1 Edge™ food additive aimed at weight management. This signals a significant advancement in the functional food and supplement industry, demonstrating the potential for AI-driven discovery platforms to create natural, clinically validated bioactives. For investors, this indicates Lembas's readiness to commercialize its proprietary technology and enter a high-demand market with a novel solution for metabolic health.
Log in to access full profile ›Company Intelligence Q&A
- When was Lembas founded?
- Lembas was founded in May 2024.
- Who are the founders of Lembas?
- Lembas was founded by Gil Horsky, Shay Hilel, and Prof. Maayan.
- What is Lembas's primary product?
- Lembas's lead product is GLP-1 Edge™, a food-grade peptide designed to enhance the body’s GLP-1 response for appetite regulation and metabolic health.
- When did Lembas emerge from stealth mode?
- Lembas emerged from stealth in June 2025, announcing its breakthrough discovery in natural GLP-1 for weight management.
- Which investors participated in Lembas's funding round?
- In June 2025, Lembas received funding from FLORA Ventures and Fresh Fund.